Search
- Sep 26, 2023
The head of Novo Nordisk's Bio Innovation Hub on collaborating to modify cardiometabolic diseases
Uli Stilz talks about the collaborating on science that might slow or reverse the progression of cardiometabolic diseases.
Also look for unique social pages for BiotechTV U.
#1. Ultragenyx's Emil Kakkis on Angelman syndrome data, rare disease treatment modalities, and more
#2. The CEO of Madrigal on the launch of Rezdiffra for NASH liver disease
#3. Sutro Biopharma's CEO on ADCs, non-cell protein synthesis, and more
#4. Verve Therapeutics' CEO on today's gene editing clinical trial pause
#5. Daphne Zohar on becoming the CEO of Seaport Therapeutics and a $100M series A